Search Results - "RAMKUMAR, Stephanie"

Understanding Palliative Interventions in Patients with End-Stage Colorectal Cancer by Ramkumar, Stephanie, MD, Liang, Shuyin V., MD, Prince, Rebecca M., MBBS, FRACP, Scheer, Adena S, Hallet, Julie, MD, Wong, Rebecca K, Krzyzanowska, Monica, Kortan, Paul, Zimmermann, Camilla, MD, PhD, Easson, Alexandra M., MD, FACS

Get full text

Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro by Shi, Pei Lin, Binnington, Beth, Sakac, Darinka, Katsman, Yulia, Ramkumar, Stephanie, Gariepy, Jean, Kim, Minji, Branch, Donald R, Lingwood, Clifford

“…Our previous genetic, pharmacological and analogue protection studies identified the glycosphingolipid, Gb(3) (globotriaosylceramide, Pk blood group antigen)…”
Get full text

The Importance of Applying ACOSOG Z0011 Criteria in the Axillary Management of Invasive Lobular Carcinoma: A Multi-institutional Cohort Study by Roberts, Amanda, Nofech-Mozes, Sharon, Youngson, Bruce, McCready, David R., Al-Assi, Manar, Ramkumar, Stephanie, Cil, Tulin

“…Background The American College of Surgeons Oncology Group (ACOSOG) Z0011 trial led to a significant change in the management of patients with early stage…”
Get full text

Quality matters: Patterns of palliative interventions in metastatic colorectal cancer (mCRC) patients by Prince, Rebecca M., Liang, Shuyin, Brar, Mantaj, Ramkumar, Stephanie, Scheer, Adena, Wong, Rebecca, Hallet, Julie I., Zimmermann, Camilla, Easson, Alexandra Maria

“…Abstract only 83 Background: Increasing recognition that high-quality end of life care is essential has resulted in internationally endorsed metrics allowing…”
Get full text

Breast cancer histology and non-sentinel lymph node involvement following a positive sentinel lymph node biopsy: A multi-institutional cohort study by Hosein, Alana, LeBlanc, Dominique, Roberts, Amanda, Cordeiro, Erin, Nofech-Mozes, Sharon, Youngson, Bruce, McCready, David R., Al-Assi, Manar, Ramkumar, Stephanie, Cil, Tulin

“…Abstract only…”
Get full text

The human P(k) histo-blood group antigen provides protection against HIV-1 infection by Lund, Nicole, Olsson, Martin L, Ramkumar, Stephanie, Sakac, Darinka, Yahalom, Vered, Levene, Cyril, Hellberg, Asa, Ma, Xue-Zhong, Binnington, Beth, Jung, Daniel, Lingwood, Clifford A, Branch, Donald R

“…Several human histo-blood groups are glycosphingolipids, including P/P1/P(k). Glycosphingolipids are implicated in HIV-host-cell-fusion and some bind to…”
Get full text

The human Pk histo-blood group antigen provides protection against HIV-1 infection by Lund, Nicole, Olsson, Martin L., Ramkumar, Stephanie, Sakac, Darinka, Yahalom, Vered, Levene, Cyril, Hellberg, Åsa, Ma, Xue-Zhong, Binnington, Beth, Jung, Daniel, Lingwood, Clifford A., Branch, Donald R.

“…Several human histo-blood groups are glycosphingolipids, including P/P1/Pk. Glycosphingolipids are implicated in HIV-host-cell-fusion and some bind to…”
Get full text

synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms by Harrison, Amanda L, Olsson, Martin L, Jones, R. Brad, Ramkumar, Stephanie, Sakac, Darinka, Binnington, Beth, Henry, Stephen, Lingwood, Clifford A, Branch, Donald R

“…Previously, it was shown that the cell-membrane-expressed glycosphingolipid, globotriaosylceramide (Gb₃/Pk/CD77), protects against HIV-1 infection and may be a…”
Get full text

Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels by Ramkumar, Stephanie, Sakac, Darinka, Binnington, Beth, Branch, Donald R, Lingwood, Clifford A

“…To examine the role of the glycosphingolipid (GSL), globotriaosylceramide (Gb₃, CD77, pk blood group antigen) in HIV-1 infection, we have pharmacologically…”
Get full text

Chemical treatment of anti-D results in improved efficacy for the inhibition of Fcgamma receptor-mediated phagocytosis by Foo, Alison H, Ramkumar, Stephanie, Helke, Simone, Branch, Donald R

“…This study investigated whether treatment of immunoglobulins anti-D or intravenous immune globulin (IVIG) with chemicals previously shown to inhibit…”
Get full text

The human P-k histo-blood group antigen provides protection against HIV-1 infection by Lund, Nicole, Olsson, Martin L, Ramkumar, Stephanie, Sakac, Darinka, Yahalom, Vered, Levene, Cyril, Hellberg, Åsa, Ma, Xue-Zhong, Binnington, Beth, Jung, Daniel, Lingwood, Clifford A., Branch, Donald R.

“…Several human histo-blood groups are glycosphingolipids, including P/P1/P-k. Glycosphingolipids are implicated in HIV-host-cell-fusion and some bind to…”
Get full text

The human Pk histo-blood group antigen provides protection against HTV-1 infection by LUND, Nicole, OLSSON, Martin L, LINGWOOD, Clifford A, BRANCH, Donald R, RAMKUMAR, Stephanie, SAKAC, Darinka, YAHALOM, Vered, LEVENE, Cyril, HELLBERG, Asa, MA, Xue-Zhong, BINNINGTON, Beth, JUNG, Daniel

Get full text

Chemical treatment of anti-D results in improved efficacy for the inhibition of Fcγ receptor-mediated phagocytosis by Foo, Alison H., Ramkumar, Stephanie, Helke, Simone, Branch, Donald R.

“…BACKGROUND: This study investigated whether treatment of immunoglobulins anti‐D or intravenous immune globulin (IVIG) with chemicals previously shown to…”
Get full text

Induction of resistance to HIV-1 infection: Susceptibility is an inverse function of globotriaosylceramide (Gb(3)/P(k)) expression by Ramkumar, Stephanie R

“…Based on previous findings, we propose that Gb3 is a natural resistance factor against HIV infection. CD4+ HeLa cells were used to increase Gb3 expression via…”
Get full text